Officially founded in 1985 and in the years since has acquired 10 companies to become a top-tier CRO. INC Research now has more than 5,400+ personnel working in 50 countries. INC Research specializes in the planning, management, and execution of clinical trials from early phase studies through Phase IIb-IV and post approval. Studies range from small studies to large multi-national efforts for pharmaceutical, biotech and medical device companies. INC Research's 2011 purchase of Kendle International vaulted INC Research enhanced the company's therapeutic, operational and regional expertise giving INC Research the size and scale necessary to compete with top-tier CROs. In 2014 INC Research went public with an IPO which raised $150M in proceeds.
INC has the scalability and scope of services to handle even the largest pharmaceutical clients as evidenced by their strategic partnership with Otsuka, which accounts for approximately 15% of revenue. Our panel viewed INC Research as.................................
<Thumbnail and link to interactive dashboard to research more...>